THE ARISING · Longevity & Healthspan · Long Reads
Fat Molecules Get Longer With Age Across Species, and Reversing It Extended Worm Lifespan
A Nature Aging study finds lipid chains lengthen with age in mice, worms, flies and people. Blocking one enzyme reversed this in worms and helped them live longer. Human benefit is untested.
Every cell membrane is built from fats, and those fats come in different lengths. A new study finds that, with age, the balance shifts toward longer chains. The pattern shows up in mice, worms, flies and humans. In worms, pushing it back extended life.
Our research desk reported that researchers in Nature Aging found lipid chains grow longer with age across four species. Longer chains also appeared as human heart disease progressed, and dietary restriction shortened heart lipids in mice.
The desk said an enzyme called Plb1 regulates this remodeling. Its expression correlated with lifespan in mice, and genetic analyses supported a causal role in human frailty. Reducing Plb1 in worms reversed the lengthening and extended lifespan.
According to PubMed, the study, "Longer lipids mark aging and constrain lifespan," was published October 6 in Nature Aging. The senior author is Georges Janssens of Amsterdam UMC. Co-authors include aging researchers Linda Partridge and Johan Auwerx.
The team measured lipids across many tissues and species. With age, longer lipid chains rose and shorter ones fell. The authors call it a ratio shift, not just an addition of long chains.
The author list spans labs in Amsterdam, Lausanne, Cologne, Sheffield, Luxembourg, Maastricht, Düsseldorf, Ohio and California. That breadth matters. Different groups supplied different species and tissues, which makes the shared pattern harder to dismiss as one lab's quirk.
The heart findings came from human tissue. Lipid chains lengthened as heart disease progressed. In mice, eating less shortened heart lipids, which fits with dietary restriction's known effects on aging in animals.
The causal step was in worms. Knocking down Plb1 reversed lipid lengthening and extended lifespan. The benefit depended on lipid length, which supports a role for chain length in that experimental system. It does not establish a human treatment.
This adds a candidate hallmark of aging: a measurable, shared shift in membrane fats. Because it appears across species and in diseased human hearts, it could become a marker worth tracking.
Nobody has shown that shortening lipids improves health in people.
Worm results also translate poorly. Many interventions that extend worm life do little in mammals. The next real test is whether lowering Plb1 helps mice live longer or healthier.
• Do not buy supplements marketed as "lipid shortening" or Plb1-targeting. No human evidence supports them. • Keep to proven basics for heart and metabolic health: regular exercise, sleep, and a diet that avoids chronic overeating.
• If you are considering calorie restriction or long fasting, talk with your doctor first, especially if you are older, underweight, or have diabetes or heart disease.
• Open question: whether reducing Plb1 helps mammals, and whether doing so carries harms.
• Mouse studies that lower Plb1 and measure lifespan and healthspan. • Whether blood lipid chain length can serve as an aging marker in human cohorts. • Independent replication of the cross-species lipid pattern.